It stabilizes pro-tumorigenic KYNU protein (95), promotes cancer stemness via WNT/β-catenin signaling (136), inhibits ferroptosis through the miR-335-5p/GPX4 axis (20), and modulates innate immunity via DHX9 interaction (42). This evidence concerns the gene GPX4 and cancer.